Bitter melon peptide: a protein-based approach to blood-sugar support
Blood-sugar formulas have long relied on charantin-standardised extracts. Peptide-grade material - produced by controlled enzymatic hydrolysis of fresh bitter melon seed germs - is quietly taking share.
The commercial appeal is straightforward: rapid onset (about 30 minutes), a 4-8 hour window that covers post-meal glucose, and no hypoglycemia episodes reported at standard doses.
We produce bitter melon peptide at 75% and 85% with molecular weight 500-1,000 Da. Sample COAs show the full amino acid profile on request.